Table 4. Open in new tab Predictive...

Variable

95% CI

P-value

Female versus male

0.58

0.54–0.63

<0.0001

BMI (kg/m²)

23–25 (reference)

1.0

–

<18.5 versus 23–25

0.08

0.04–0.16

<0.0001

<23 versus 23–25

0.43

0.37–0.50

<0.0001

≥25–<30 versus 23–25

2.49

2.22–2.80

<0.0001

≥30 versus 23–25

10.41

9.24–11.72

<0.0001

Cancer versus no cancer

1.15

1.02–1.29

0.0245

Vascular access at last point

–

AVF (reference)

1.0

–

Other vascular access versus AVF

0.58

0.40–0.84

<0.0001

Tunnelled catheter versus AVF

0.49

0.45–0.55

<0.0001

Graft versus AVF

0.72

0.58–0.90

<0.0001

HD (reference)

1.0

–

Acetate-free biofiltration versus HD

0.71

0.08–6.14

–

Haemodiafiltration versus HD

2.92

2.71–3.14

<0.0001

Haemofiltration versus HD

3.82

1.95–7.46

<0.0001

Weekly duration of dialysis (h)

4.54

3.99–5.17

<0.0001

Emergency start versus scheduled start

0.87

0.80–0.94

0.0008

eKt/V (reference)

1.0

–

Method of measure ‘other’ versus eKt/V

0.89

0.64–1.23

–

Method of measure dKt/V versus eKt/V

0.57

0.52–0.62

<0.0001

Method of measure spKt/V versus eKt/V

1.43

1.30–1.58

<0.0001

Method of measure not available versus eKt/V

0.90

0.80–1.01

–

Table 4.

Open in new tab

Predictive factors of Kt in the upper quartile (>69 L) with their ORs and 95% CIs

Variable	OR	95% CI	P-value
Female versus male	0.58	0.54–0.63	<0.0001
BMI (kg/m²)
23–25 (reference)	1.0	–	–
<18.5 versus 23–25	0.08	0.04–0.16	<0.0001
<23 versus 23–25	0.43	0.37–0.50	<0.0001
≥25–<30 versus 23–25	2.49	2.22–2.80	<0.0001
≥30 versus 23–25	10.41	9.24–11.72	<0.0001
Cancer versus no cancer	1.15	1.02–1.29	0.0245
Vascular access at last point	–	–	–
AVF (reference)	1.0	–	–
Other vascular access versus AVF	0.58	0.40–0.84	<0.0001
Tunnelled catheter versus AVF	0.49	0.45–0.55	<0.0001
Graft versus AVF	0.72	0.58–0.90	<0.0001
HD (reference)	1.0	–	–
Acetate-free biofiltration versus HD	0.71	0.08–6.14	–
Haemodiafiltration versus HD	2.92	2.71–3.14	<0.0001
Haemofiltration versus HD	3.82	1.95–7.46	<0.0001
Weekly duration of dialysis (h)	4.54	3.99–5.17	<0.0001
Emergency start versus scheduled start	0.87	0.80–0.94	0.0008
eKt/V (reference)	1.0		–
Method of measure ‘other’ versus eKt/V	0.89	0.64–1.23	–
Method of measure dKt/V versus eKt/V	0.57	0.52–0.62	<0.0001
Method of measure spKt/V versus eKt/V	1.43	1.30–1.58	<0.0001
Method of measure not available versus eKt/V	0.90	0.80–1.01	–

Variable	OR	95% CI	P-value
Female versus male	0.58	0.54–0.63	<0.0001
BMI (kg/m²)
23–25 (reference)	1.0	–	–
<18.5 versus 23–25	0.08	0.04–0.16	<0.0001
<23 versus 23–25	0.43	0.37–0.50	<0.0001
≥25–<30 versus 23–25	2.49	2.22–2.80	<0.0001
≥30 versus 23–25	10.41	9.24–11.72	<0.0001
Cancer versus no cancer	1.15	1.02–1.29	0.0245
Vascular access at last point	–	–	–
AVF (reference)	1.0	–	–
Other vascular access versus AVF	0.58	0.40–0.84	<0.0001
Tunnelled catheter versus AVF	0.49	0.45–0.55	<0.0001
Graft versus AVF	0.72	0.58–0.90	<0.0001
HD (reference)	1.0	–	–
Acetate-free biofiltration versus HD	0.71	0.08–6.14	–
Haemodiafiltration versus HD	2.92	2.71–3.14	<0.0001
Haemofiltration versus HD	3.82	1.95–7.46	<0.0001
Weekly duration of dialysis (h)	4.54	3.99–5.17	<0.0001
Emergency start versus scheduled start	0.87	0.80–0.94	0.0008
eKt/V (reference)	1.0		–
Method of measure ‘other’ versus eKt/V	0.89	0.64–1.23	–
Method of measure dKt/V versus eKt/V	0.57	0.52–0.62	<0.0001
Method of measure spKt/V versus eKt/V	1.43	1.30–1.58	<0.0001
Method of measure not available versus eKt/V	0.90	0.80–1.01	–

dKt/V, ionic dialysance Kt/V.

This Feature Is Available To Subscribers Only